BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2833479)

  • 1. Adrenocorticotropin-containing neoplastic cells in a pars intermedia adenoma in a horse.
    Horvath CJ; Ames TR; Metz AL; Larson VL
    J Am Vet Med Assoc; 1988 Feb; 192(3):367-71. PubMed ID: 2833479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical localization of adrenocorticotropic hormone-immunoreactive cells of the pars intermedia in thoroughbreds.
    Okada T; Shimomuro T; Oikawa M; Nambo Y; Kiso Y; Morikawa Y; Liptrap RM; Yamashiro S; Little PB; Sasaki F
    Am J Vet Res; 1997 Aug; 58(8):920-4. PubMed ID: 9256982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equine pituitary neoplasia: a clinical report of 21 cases (1990-1992).
    van der Kolk JH; Kalsbeek HC; van Garderen E; Wensing T; Breukink HJ
    Vet Rec; 1993 Dec; 133(24):594-7. PubMed ID: 8116170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of pituitary adrenocorticotropin-dependent Cushing's syndrome in the horse.
    Moore JN; Steiss J; Nicholson WE; Orth DN
    Endocrinology; 1979 Mar; 104(3):576-82. PubMed ID: 220013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia.
    Beech J; Boston R; Lindborg S; Russell GE
    J Am Vet Med Assoc; 2007 Aug; 231(3):417-26. PubMed ID: 17669045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A horse with Cushing's disease].
    van der Kolk JH; Klein WR; van der Putten SW; Mol JA
    Tijdschr Diergeneeskd; 1991 Jul; 116(13):670-5. PubMed ID: 1650504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary-dependent hyperadrenocorticism in a cat.
    Peterson ME; Steele P
    J Am Vet Med Assoc; 1986 Sep; 189(6):680-3. PubMed ID: 3019973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory diagnosis of equine pituitary pars intermedia adenoma.
    van der Kolk JH; Wensing T; Kalsbeek HC; Breukink HJ
    Domest Anim Endocrinol; 1995 Jan; 12(1):35-9. PubMed ID: 7621678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of pituitary gland anatomy and histopathologic findings in clinically normal horses and horses and ponies with pituitary pars intermedia adenoma.
    van der Kolk JH; Heinrichs M; van Amerongen JD; Stooker RC; in de Wal LJ; van den Ingh TS
    Am J Vet Res; 2004 Dec; 65(12):1701-7. PubMed ID: 15631037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a combined dexamethasone suppression/thyrotropin-releasing hormone stimulation test in healthy horses and horses suspected to have a pars intermedia pituitary adenoma.
    Eiler H; Oliver JW; Andrews FM; Fecteau KA; Green EM; McCracken M
    J Am Vet Med Assoc; 1997 Jul; 211(1):79-81. PubMed ID: 9215417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic testing for pituitary pars intermedia dysfunction in horses.
    Dybdal NO; Hargreaves KM; Madigan JE; Gribble DH; Kennedy PC; Stabenfeldt GH
    J Am Vet Med Assoc; 1994 Feb; 204(4):627-32. PubMed ID: 8163420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical symptoms of and diagnostic possibilities for hypophyseal adenoma in horses].
    Feige K; Eser MW; Geissbühler U; Balestra E; Metzler K
    Schweiz Arch Tierheilkd; 2000 Feb; 142(2):49-54. PubMed ID: 10697998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid metabolism in horses with hyperadrenocorticism.
    van der Kolk JH; Wensing T; Kalsbeek HC; Breukink HJ
    J Am Vet Med Assoc; 1995 Apr; 206(7):1010-2. PubMed ID: 7768707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenomas of the pars intermedia associated with hyperglycemia and glycosuria in two horses.
    Loeb WF; Capen CC; Johnson LE
    Cornell Vet; 1966 Oct; 56(4):623-39. PubMed ID: 6008349
    [No Abstract]   [Full Text] [Related]  

  • 15. Somatotroph and corticotroph pituitary adenoma (double adenoma) in a cat with diabetes mellitus and hyperadrenocorticism.
    Meij BP; van der Vlugt-Meijer RH; van den Ingh TS; Rijnberk A
    J Comp Pathol; 2004; 130(2-3):209-15. PubMed ID: 15003481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanotroph pituitary adenoma in a cat with diabetes mellitus.
    Meij BP; van der Vlugt-Meijer RH; van den Ingh TS; Flik G; Rijnberk A
    Vet Pathol; 2005 Jan; 42(1):92-7. PubMed ID: 15657280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary pars intermedia dysfunction with pituitary gland melanotroph adenoma in a Grevy's zebra (Equus grevyi).
    Takahashi N; Chambers JK; Ota K; Toda K; Yoshimoto Y; Miyajima U; Uchida K
    J Vet Med Sci; 2024 Jan; 86(1):71-76. PubMed ID: 37981318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypophyseal adenocarcinoma in a horse. A case study].
    Martens J; Rosenbruch M
    Tierarztl Prax; 1984; 12(3):354-8. PubMed ID: 6495317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoma of the pars intermedia and hirsutism in a pony.
    Holscher MA; Linnabary RL; Netsky MG; Owen HD
    Vet Med Small Anim Clin; 1978 Sep; 73(9):1197-200. PubMed ID: 252364
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunocytochemical demonstration of proopiomelanocortin-derived peptides in pituitary adenomas of the pars intermedia in horses.
    Heinrichs M; Baumgärtner W; Capen CC
    Vet Pathol; 1990 Nov; 27(6):419-25. PubMed ID: 2177580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.